| __timestamp | Pharming Group N.V. | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 2917513 |
| Thursday, January 1, 2015 | 5279557 | 7878291 |
| Friday, January 1, 2016 | 8073913 | 8366794 |
| Sunday, January 1, 2017 | 44864073 | 6610381 |
| Monday, January 1, 2018 | 53488904 | 6556000 |
| Tuesday, January 1, 2019 | 65896361 | 6930000 |
| Wednesday, January 1, 2020 | 69968267 | 8758000 |
| Friday, January 1, 2021 | 92047281 | 10806000 |
| Saturday, January 1, 2022 | 131819000 | 9844000 |
| Sunday, January 1, 2023 | 87501000 | 13481000 |
Unleashing insights
In the competitive world of pharmaceuticals and therapeutics, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Pharming Group N.V. and Soleno Therapeutics, Inc. have shown contrasting approaches to handling these costs. From 2014 to 2023, Pharming Group N.V. saw a staggering increase in SG&A expenses, peaking in 2022 with a 2,600% rise from 2014. In contrast, Soleno Therapeutics, Inc. maintained a more stable trajectory, with expenses increasing by approximately 360% over the same period.
Pharming's expenses surged notably in 2017, reflecting strategic investments or operational expansions. Meanwhile, Soleno's steadier growth suggests a more controlled cost management strategy. As investors and analysts evaluate these companies, understanding their SG&A trends offers insights into their operational efficiencies and strategic priorities.
Selling, General, and Administrative Costs: Eli Lilly and Company vs Pharming Group N.V.
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Regeneron Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Viatris Inc. vs Pharming Group N.V. Trends and Insights
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Pharming Group N.V.
Comparing SG&A Expenses: Pharming Group N.V. vs Xenon Pharmaceuticals Inc. Trends and Insights
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Apellis Pharmaceuticals, Inc. or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared